Qingdao Deluer International Trade Co., Ltd – Trademark Portfolio

Entity Type: 99

Qingdao Deluer International Trade Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include DELUR. The owner is based in Qingdao.

S Zone, Rm301,#2,Bldg 2,Shandong Laoshan

No 872, Tong'an Rd, Hai'er Dongchengg

Qingdao 266100 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DELUR
DELUR
Registered 2020

Trademark Classifications

Qingdao Deluer International Trade Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Qingdao Deluer International Trade Co., Ltd have?

Qingdao Deluer International Trade Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Qingdao Deluer International Trade Co., Ltd file in?

Qingdao Deluer International Trade Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Qingdao Deluer International Trade Co., Ltd's most well-known trademarks?

Qingdao Deluer International Trade Co., Ltd's registered trademark portfolio includes well-known marks such as DELUR. These are among 1 currently registered trademark in the portfolio.

What is Qingdao Deluer International Trade Co., Ltd's trademark registration success rate?

Qingdao Deluer International Trade Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.